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Abstract
Identification of neural circuit changes contributing to behavioral plasticity has routinely been 
conducted on candidates that were preselected based on past results. Here we present an unbiased 
method for identifying experience-triggered circuit-level changes in neuronal ensembles. Using 
rabies virus monosynaptic tracing we mapped cocaine-induced global input changes onto ventral 
tegmental area (VTA) neurons. Cocaine increased rabies labeled inputs from the globus pallidus 
externus (GPe), a basal ganglia nucleus previously not known to participate in behavioral plasticity 
triggered by drugs of abuse. We demonstrated that cocaine increased GPe neuron activity, which 
accounted for the increase in GPe labeling. Inhibition of GPe activity revealed its vital role in two 
different forms of cocaine-triggered behavioral plasticity, at least in part via GPe-mediated 
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disinhibition of VTA dopamine neuron activity. These results suggest that rabies-based unbiased 
screening of changes in input populations can identify previously unappreciated circuit elements 
that critically support behavioral adaptations.
Plasticity in neuronal circuits enables animals to adapt to an ever-changing environment. 
However, the loci and nature of experience-dependent changes in circuit function that drive 
adaptive and pathological behaviors remain largely unknown. While modern techniques such 
as optogenetics1 and chemogenetics2 permit sequential screening of targeted elements in 
circuits with complex input and output patterns, unbiased approaches are necessary to 
identify new components that play critical roles in the behavioral changes of interest. One 
such approach uses the expression of immediate early genes to identify the neuronal 
ensembles activated by a defined experience3,4 but as currently utilized, this approach does 
not reveal the connectivity of these ensembles. Brain imaging techniques such as fMRI or 
PET also provide insights into unexpected experience-dependent macroscopic connectivity 
changes but lack cellular resolution. Thus, there is a need for additional methods that 
facilitate unbiased identification of circuit substrates of experience-dependent behavioral 
changes. Here, we present evidence that the rabies virus-based monosynaptic tracing 
technique facilitates screening of circuit elements that contribute to behavioral changes by 
allowing whole-brain mapping of monosynaptic inputs5,6 to defined starter neuronal 
populations and their input/output relationships7–9.
To test the utility of a rabies virus-based approach for screening of behaviorally relevant 
experience-dependent circuit adaptations, we initially focused on the VTA, a circuit node 
critical for a variety of experience-dependent behaviors10–12. The diverse array of inputs to 
and input-output relationships of VTA dopamine (DA) and GABA cells have been 
extensively elucidated using rabies virus methods5,7. As a robust trigger of experience-
dependent plasticity we administered drugs of abuse focusing on cocaine, which elicits long-
lasting behavioral adaptations including locomotor sensitization (LMS) and conditioned 
place preference (CPP). Our unbiased input screen revealed an unexpected critical role for 
the GPe, which has been implicated in motor control13, habit formation14, and Parkinson’s 
disease15 but ignored when studying addiction-related behaviors triggered by drugs of abuse. 
Our findings provide proof of principle for the utility of this approach while implicating the 
GPe as playing a vital function for the establishment of drug-evoked behavioral plasticity.
Screen for cocaine-induced input changes
Cocaine administration induces modification of synapses on VTA-DA and VTA-GABA 
neurons16 but the identities of cells providing those inputs are largely unknown. To test 
whether rabies virus monosynaptic tracing might reveal the identity of inputs altered by 
cocaine, we first employed the rabies monosynaptic input tracing technique17, where 
animals were given a single injection of cocaine (15 mg/kg) or saline one day prior to 
injection of the rabies virus, RVdG (Fig. 1a). Unbiased analysis of the labeled input cells 
from 22 different brain regions comprising >90% of long-range inputs to VTA-DA neurons 
revealed that while the global maps were quantitatively similar, labeling proportionally 
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increased or decreased in a small subset of regions in cocaine-treated animals, with inputs 
from the GPe displaying the largest magnitude proportional change (Fig. 1b).
To determine if similar labeling changes occurred in response to different classes of abused 
substances, as occurs with synaptic adaptations onto VTA-DA neurons16, we administered 
single doses of amphetamine, morphine, nicotine, or the psychoactive but non-addictive 
substance fluoxetine. The drugs of abuse increased labeling of GPe cells while fluoxetine 
did not (Fig. 1c, Extended Data Fig. 1a). As previous work using rabies virus revealed that 
VTA-DA and VTA-GABA neurons receive similar inputs7, we next used the GAD2-Cre 
mouse driver line to test if cocaine induced similar changes in labeling of cells making 
monosynaptic contacts onto midbrain GABA neurons in the VTA and the nearby substantia 
nigra pars reticulata (SNr) (Fig. 1d). Cocaine again elicited a proportional increase in 
labeling of GPe cells compared to saline injections (Fig. 1e).
Cocaine enhances GPe-PV neuron activity
The four brain regions exhibiting the largest drug-induced change in labeling were the GPe, 
anterior cortex (Ant. Ctx.), medial habenula (MHb), and nucleus accumbens medial shell 
(NAcMedS) (Fig. 1c, Extended Data Fig. 1a). While the latter three are sites previously 
implicated in the behavioral adaptations caused by drugs of abuse11, the potential role of the 
GPe has not been investigated. What does the increase in rabies virus labeling of GPe inputs 
onto VTA-DA and GABA cells indicate about the effects of cocaine? To address this 
question we used parvalbumin (PV)-Cre or PV-Flp mouse driver lines to specifically target 
GPe-PV cells as the majority of rabies-labeled GPe cells making synapses onto VTA-DA 
neurons co-stained with PV (305/367; Extended Data Fig. 1b). Visualization of axons of 
GPe-PV neurons expressing a membrane tagged GFP demonstrated that these cells send 
major projections to a range of brain regions including the forebrain and thalamus (Extended 
Data Fig. 2a, b). Consistent with prior work18, the major GPe projection to the midbrain was 
to the SNr, which contains mostly GABA neurons19, while DA neuron-containing nuclei 
such as the substantia nigra pars compacta (SNc) or VTA received fewer inputs (Extended 
Data Fig. 2c, d).
To determine if the cocaine-induced increase in rabies virus labeling of GPe cells reflected 
an increase in the number of synaptic contacts, we injected AAV-FLExloxP-mGFP-2A-
synaptophysin-mRuby, which labels putative presynaptic sites (Fig. 2a), into the GPe of PV-
Cre mice and imaged ~1 month later after a cocaine or saline injection (Fig. 2b). The density 
and volume of these puncta in the SNr were indistinguishable in saline versus cocaine-
treated animals (Fig. 2c, d), suggesting no change in synapse number occurred. Next, we 
assessed potential changes in synapse strength since single doses of drugs of abuse can 
enhance synaptic strength of both excitatory and inhibitory inputs into the ventral 
midbrain16. We injected AAV-FLExFRT-ChR2 into the GPe of PV-Flp animals and 
conducted whole-cell recordings from SNr neurons in acute slices ~1 month later. Calcium 
in the extracellular recording solution was replaced by strontium to enable measurements of 
quantal events20 (Fig. 2e, f). No change in the amplitude or frequency of quantal events was 
observed in slices prepared from cocaine versus saline treated animals (Fig. 2g, h), 
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suggesting cocaine did not elicit a change in the strength of the inhibitory synapses made by 
GPe-PV neurons on SNr neurons.
Finally, we assessed if GPe-PV neuron spontaneous activity in vivo was altered by cocaine 
by expressing the fluorescent Ca2+ indicator GCaMP6f in GPe-PV neurons and collecting 
population Ca2+-dependent signals using fiber photometry (Fig. 2i). While cocaine 
administration had no significant acute effect, population activity increased two-fold the 
following day (Fig. 2j, k). To assess if this increase might reflect changes in intrinsic 
excitability, we injected AAV-FLExloxP-GFP into the GPe of PV-Cre mice and made 
targeted whole-cell current clamp recordings from acute GPe slices prepared one day after 
animals received saline or cocaine injections (Fig. 2l). GPe-PV neurons from cocaine-treated 
animals were more excitable in that more action potentials were generated by depolarizing 
current injection steps (Fig. 2m, n) with no change in cells’ input resistances (Fig. 2n). These 
results demonstrate that a single exposure to cocaine triggers increases in the spontaneous 
activity and excitability of GPe-PV neurons.
Input activity modulates rabies labeling
Are the cocaine-induced changes in rabies virus labeling of GPe-PV input neurons due to 
the observed changes in their activity? To address this possibility, we expressed transgenes 
in GPe-PV neurons that permit manipulation of their activity levels while simultaneously 
performing rabies virus transsynaptic labeling. Chronic activity manipulations bi-
directionally influenced the extent of GPe neuronal labeling: chronic inhibition of GPe-PV 
neuron activity with the inhibitory DREADD hM4Di2 or Kir2.121 decreased rabies virus 
labeling of GPe neurons compared to control and YFP-expressing animals while the 
excitatory manipulation using hM3Dq2, on average, increased labeling (Fig. 3d). As a 
control for these manipulations, we examined labeling in the NAcMedS and found no effect 
due to expressing any of these transgenes in GPe-PV neurons (Fig. 3e).
To determine if the effects of chronic activity changes on rabies virus transsynaptic labeling 
generalized to other brain regions, we performed the same genetic manipulations on 
NAcMedS-D1 receptor-expressing medium spiny neurons (MSNs), the labeling of which 
was decreased by drugs of abuse (Fig. 1c; Extended Data Fig. 1a, c). Parallel to the effects of 
manipulating GPe-PV neurons, chronic NAcMedS inhibition using hM4Di or Kir2.1 reduced 
labeled inputs in the NAcMedS, while activation with hM3Dq enhanced NAcMedS labeling 
(Fig. 3h). Unexpectedly, while NAcMedS inhibition did not alter labeling of GPe neurons, 
NAcMedS activation increased labeled GPe inputs (Fig. 3g), suggesting that NAcMedS-D1 
MSN activation indirectly increases GPe activity. Together, these experiments provide 
evidence that rabies-mediated transsynaptic labeling from starter neurons is influenced by 
the level of activity in input cell populations. Furthermore, they support the hypothesis that 
cocaine as well as other drugs of abuse chronically increases the level of GPe-PV neuron 
activity and this accounts for the observed increase in their labeling by the rabies virus.
Beier et al. Page 4
Nature. Author manuscript; available in PMC 2018 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Behavioral changes require GPe activity
To determine if the cocaine-elicited changes in GPe-PV neuron activity revealed by rabies 
virus tracing are functionally relevant and necessary for cocaine-induced behavioral 
adaptations, we examined if inhibition of GPe-PV neurons influenced two forms of cocaine-
induced behavioral plasticity, LMS and CPP. Inhibition of activity in GPe-PV neurons using 
expression of any one of three different transgenes, hM4Di, Kir2.1, or the tetanus toxin light 
chain (TeTxLc), which inhibits presynaptic vesicle release22, prevented cocaine-induced 
LMS (Fig. 4a-c), while having no effect on basal locomotion and only a modest effect on 
cocaine-induced locomotion upon initial administration (Extended Data Fig. 3). 
Furthermore, there was a positive correlation between the number of rabies-labeled GPe 
inputs and the magnitude of LMS in a two-day injection protocol for cocaine as well as 
other addictive drugs (Extended Data Fig. 4). Similar results were obtained for cocaine-
elicited CPP: using a four-day protocol (Fig. 4d), inhibition of GPe-PV activity via 
expression of hM4Di, Kir2.1, or TeTxLc prevented CPP (Fig. 4e, f). Inhibition of GPe-PV 
neurons with hM4Di also prevented morphine-induced LMS and CPP (Extended Data Fig. 
5), implying that the role of these neurons may generalize to other abused substances.
A limitation of these experiments is that GPe-PV neurons project to several different brain 
regions (Extended Data Fig. 2) and thus the transgene-mediated inhibition of these neurons 
was not target-specific. To limit expression of an inhibitory transgene specifically to those 
GPe-PV neurons projecting to the midbrain, we injected a retrogradely-transported CAV-
FLExloxP-Flp into the midbrain of PV-Cre mice and a Flp-dependent AAV-FLExFRT-Kir2.1 
into the GPe, enabling Kir2.1 expression only in Cre-expressing GPe-PV neurons projecting 
to the midbrain (Extended Data Fig. 6a). This manipulation prevented both cocaine-elicited 
LMS and CPP (Extended Data Fig. 6b, c). However, subsequent axon tracing experiments 
revealed that the GPe-PV neurons projecting to the midbrain collateralize extensively 
(Extended Data Fig. 7), limiting the interpretation of this experiment. To specifically inhibit 
the GPe-PV neuron projections within the midbrain, we expressed hM4Di in GPe-PV 
neurons and infused slow-release CNO microspheres23 into the midbrain (Fig. 4g). This 
local inhibition was sufficient to block both cocaine-induced LMS (Fig. 4h) and CPP (Fig. 
4i). After waiting a week to allow for depletion of CNO, these same animals were re-tested 
using the same protocols, and expressed significant LMS and CPP (Fig. 4h, i). These results 
demonstrate that activity in the projection of GPe-PV neurons to the midbrain is necessary 
for two different forms of cocaine-induced behavioral plasticity.
GPe-PV neurons disinhibit VTA-DA neurons
Does the cocaine-induced increase in activity in inhibitory GPe-PV neurons influence DA 
cell activity, which is required for induction of LMS and CPP (Extended Data Fig. 8)? Given 
that the major projection from GPe-PV neurons to the midbrain is into the SNr (Extended 
Data Fig. 2), a simple hypothesis is that GPe-PV neurons strongly inhibit SNr neurons that 
tonically inhibit DA neurons. Thus, activation of GPe-PV neurons would increase DA 
neuron activity via disinhibition despite some direct synaptic inhibition of DA cells. We 
tested this hypothesis in several ways. First, to examine the functional strength of GPe-PV 
neuron connections to midbrain DA and GABA neurons, we injected a Flp-dependent AAV 
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expressing channelrhodopsin (AAV-FLExFRT-ChR2) into the GPe of either DAT-Cre;PV-Flp 
or GAD2-Cre;PV-Flp double transgenic animals, AAV-FLExloxP-GFP into the VTA to label 
DA or GABA neurons (Fig. 5a), and retrobeads into either the NAcMedS or nucleus 
accumbens lateral shell (NAcLatS) to demarcate one of two VTA-DA subpopulations whose 
inputs are modified by cocaine24. We then assayed monosynaptic inhibitory postsynaptic 
currents (IPSCs) via whole-cell recordings in acute slices. Optical stimulation of GPe-PV 
neuron axons evoked large IPSCs in the majority (63%, n=24) of SNr-GABA neurons (Fig. 
5b-c). In the same sets of slices using the same optical stimulation, the connectivity onto 
VTA neurons was much smaller (5-14%) as was the size of the IPSCs in cells in which they 
could be detected (Fig. 5b, c, Extended Data Fig. 9). These results demonstrate that 
functionally, GPe-PV neurons exhibit much stronger inhibitory connections onto SNr-
GABA neurons than VTA-DA or VTA-GABA neurons and thus the GPe-PV synapses in the 
VTA appear to be of limited functional importance.
Second, we tested if manipulating activity in SNr-GABA neurons could impact the 
development of LMS and CPP. Activating SNr-GABA neurons via hM3Dq prevented the 
development of LMS and CPP (Extended Data Fig. 10a-c) while concurrently inhibiting 
SNr-GABA neurons via hM4Di during chronic GPe-PV neuron inhibition rescued cocaine-
mediated behavioral plasticity (Extended Data Fig. 10d-f). These results suggest that GPe-
PV neuron inhibition prevents LMS and CPP by enhancing activity of SNr-GABA neurons.
Third, we examined if SNr-GABA neurons provide direct inhibition to DA neurons using a 
modified rabies virus input tracing strategy25 to label local inputs onto DA neurons and 
combining this with in-situ hybridization for GAD1/2 mRNA (Fig. 5d, e). Quantitatively, 
SNr-GABA neurons were the second-largest source of inhibitory inputs to DA neurons (Fig. 
5f).
Fourth, we tested if changes in GPe-PV neuron activity influenced integrated VTA-DA 
neuron activity using Fos labeling. In YFP-expressing animals, acute cocaine administration 
caused a clear increase in Fos+ DA neurons compared to saline injected animals measured 
90 minutes after injection (Fig. 5j). Inhibition of GPe-PV neurons with hM4Di had no effect 
in saline treated animals but completely prevented the increase in cocaine treated animals, as 
did expression of Kir2.1 (Fig. 5j). Conversely, activation of GPe-PV neurons via ChR2 
increased Fos expression in DA cells to a degree similar to that elicited by cocaine (Fig. 5j).
Finally, to directly test the effect of activating GPe-PV neurons on VTA-DA neuron activity 
in vivo, we injected a Flp-dependent red-shifted opsin bReachES26 in the GPe and a Cre-
dependent GCaMP6f in the VTA of DAT-Cre;PV-Flp double transgenic mice and recorded 
population activity from VTA-DA neurons with fiber photometry while optically activating 
GPe-PV neurons (Fig. 5k). Stimulation of GPe-PV neurons caused a small but significant 
increase of GCaMP6f fluorescence in VTA-DA neurons (Fig. 5l-m). Taken together, these 
results indicate that GPe-PV neurons control VTA-DA neuron activity through a disynaptic 
disinhibition via SNr-GABA neurons (Fig. 5n).
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Concluding remarks
Connecting specific experience-dependent circuit changes with corresponding behavioral 
adaptations has been hampered by a lack of suitable methodology. While most investigations 
of circuit function rely on a candidate approach leveraging the advantages of cell-type 
specific manipulations, a limitation is the requirement of a priori assumptions regarding the 
roles of targeted populations. Given the complexity of circuit mechanisms mediating animal 
behaviors, unbiased approaches offer advantages for identifying the array of specific 
neuroplastic changes that drive behavioral changes. Here, we demonstrate that neural 
activity influences the extent of labeling by the rabies monosynaptic input-tracing method. 
This property enabled identification of circuit elements that were modified by experience in 
a behaviorally relevant manner. Specifically, the activity-dependence of rabies labeling 
enabled the identification of an underappreciated circuit node, the GPe, as a central player in 
cocaine-induced behavioral adaptations. As a core component of the dorsal striatal indirect 
pathway implicated in motor control13 and associated disorders15,27, the GPe had not 
previously been directly linked to addictive behaviors. Using a number of different assays, 
we demonstrated that the effect of enhanced GPe input to the midbrain is increased VTA-DA 
neuron activity via a mechanism of disinhibition (Fig. 5n). These findings provide a novel 
circuit mechanism for influencing VTA-DA neuron activity, the critical role of which in 
drug-induced behavioral adaptations11,28 we confirmed (Extended Data Fig. 8). Given that 
the rabies virus transsynaptic technique has been used successfully to map inputs onto cell 
populations in many brain areas5–9,29–32, we anticipate that this method will be 
generalizable and complementary to other circuit analysis methods1, 2 for elucidating how 
activity changes in connected ensembles orchestrate features of complex behaviors.
Methods
No statistical methods were used to predetermine sample size. Experiments described in 
Figures 1, 2a-h and 2l-n, 3, 5g-j and Extended Data Figs. 1a, 4, 5, 6, 8, and 10 were 
randomized and investigators were blinded to allocation and outcome assessments; all other 
experiments were not randomized and investigators were not blinded.
Mice and Viral Procedures
Generation and characterization of the DAT-Cre34, GAD2-Cre35, PV-Cre36, PV-Flp37, A2a-
Cre38, and D1-tdtomato39 mouse lines have been described previously. Mice were housed on 
a 12-hour light/dark cycle with food and water ad libitum. Males and females from a mixed 
CD1 and C57/BL6 background were used for all experiments in approximately equal 
proportions. All surgeries were done under isoflurane anesthesia. All procedures complied 
with the animal care standards set forth by the National Institute of Health and were 
approved by Stanford University’s Administrative Panel on Laboratory Animal Care and 
Administrative Panel of Biosafety.
pAAV-CAG-FLExloxP-G, pAAV-CAG-FLExloxP-TC, pAAV-CAG-FLExloxP-TC66T, pAAV-
CAG-FLExFRT-G, pAAV-CAG-FLExFRT-TC, and pCAV-FLExloxP-Flp were constructed as 
reported previously8. For construction of viruses containing Kirr2.1-2A-GFP, hM4Di-
mCherry, and hM3Dq-mCherry, pAAV-hSyn1-FLExloxP-mGFP-2A-synaptophysin-mRuby9 
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or pAAV-hSyn1-FLExFRT-mGFP-2A-synaptophysin-mRuby7 were used as templates. All 
inserts were cloned into the AscI and SalI sites between the loxP or FRT sites. hM3Dq-
mCherry or hM4Di-mCherry were PCR-amplified from pAAV-hSyn-DIO-hM3Dq-mCherry 
or pAAV-hSyn-DIO-hM4Di-mCherry, respectively40, and Kir2.1-2A-GFP was modified 
from Xue et al.41. AAV-CMV-FLExloxP-GFP-2A-TeTxLc, AAV-hSyn-FLExloxP-
ChR2(H134R)-eYFP, AAV-hSyn-FLExloxP-eYFP, and AAV-hSyn-FLExFRT-eYFP were 
purchased from the Stanford Gene and Viral Vector Core.
Transsynaptic tracing
Transsynaptic tracing studies were carried out as previously described7, with minor 
modifications. For rabies tracing, 100 nL of a 1:1 volume mixture of AAV-CAG-FLExloxP-
TC and AAV-CAG-FLExloxP-G was injected into the VTA of 4-6 week-old mice. Thirteen 
days later, a single dose of cocaine (15 mg/kg), amphetamine (10 mg/kg), nicotine (0.5 mg/
kg), morphine (10 mg/kg), fluoxetine (10 mg/kg), or saline was injected intraperitoneally 
(IP), and the mouse was placed in a new cage for thirty minutes before being returned to its 
home cage. The following day, RVdG was injected into the VTA. After recovery, mice were 
housed in a BSL2 facility for 5 days to allow for rabies spread and GFP expression. P values 
presented in Fig. 1 were not corrected for multiple comparisons.
For identification of local GABAergic inputs to VTA-DA neurons, 100 nL of a 1:1 volume 
mixture of AAV-CAG-FLExloxP-TC66T and AAV-CAG-FLExloxP-G was injected into the 
VTA of 4-6 week-old mice. Two weeks later, RVdG was injected into the VTA, and animals 
were sacrificed five days later. For in-situ hybridization, midbrain sections were stained with 
probes for Gad1 and Gad26, and imaged on a Zeiss LSM780 microscope at 20× 
magnification. Imaging, histology, and whole-brain quantification were performed as 
previously described7. In Fig. 5f, the VTA included the parabrachial pigmented area (PBP) 
and paranigral nucleus (PN). Data were averaged from three animals.
Coordinates used were (relative to Bregma, midline, or dorsal brain surface and in mm):
VTA: AP −3.20, ML 0.4, DV −4.2
NAcLat: AP +1.45, ML 1.75, DV −4.0
NAcMed: AP +1.55, ML 0.7, DV −4.0
GPe: AP −0.35, ML 1.75, DV −3.5
SNr (midbrain): AP −3.2, ML 1.1, DV −4.5
Abbreviations for brain regions made throughout the paper are listed below, in alphabetical 
order.
Ant. Ctx., anterior cortex
BNST, bed nucleus of the stria terminalis
CeA, central amygdala
DCN, deep cerebellar nuclei
DMStr, dorsomedial striatum
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DLStr, dorsolateral striatum
DR, dorsal raphe
DStr, dorsal striatum
EAM, extended amygdala
EP, entopeduncular nucleus
GPe, globus pallidus externus
IF, interfascicular nucleus
IPN, interpeduncular nucleus
LDT, laterodorsal tegmentum
LH, lateral hypothalamus
LHb, lateral habenula
MHb, medial habenula
mPFC, medial prefrontal cortex
mRT, midbrain reticular nucleus
NAcCore, nucleus accumbens core
NAcMedS, nucleus accumbens medial shell
NAcLatS, nucleus accumbens lateral shell
PBN, parabrachial nucleus
PO, preoptic nucleus
PRN, pontine reticular nucleus
PVH, paraventricular hypothalamus
SNc, substantia nigra pars compacta
SNr, substantia nigra pars reticulata
STN, subthalamic nucleus
VP, ventral pallidum
VTA, ventral tegmental area
ZI, zona incerta
The titers of viruses, based on quantitative PCR analysis, were as follows:
AAV-CAG-FLExloxP-TC, serotype 5, 2.4 × 1013 genome copies (gc)/mL;
AAV-CAG-FLExloxP-G, serotype 8, 1.0 × 1012 gc/mL;
AAV-CAG-FLExFRT-TC, serotype 5, 2.6 × 1012 gc/mL;
AAV-CAG-FLExFRT-G, serotype 8, 1.3 × 1012 gc/mL;
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AAV-CAG-FLExloxP-TC66T, serotype 2, 1.0 × 1012 gc/mL;
AAV-hSyn-FLExloxP-mGFP-2A-synaptophysin-mRuby, serotype DJ, 9.3 × 1012 
gc/mL;
AAV-hSyn-FLExloxP-hM3Dq-mCherry, serotype DJ, 4.0 × 1012gc/mL;
AAV-hSyn-FLExloxP-hM4Di-mCherry, serotype DJ, 5.5 × 1012 gc/mL;
AAV-hSyn-FLExloxP-Kir2.1-T2A-GFP, serotype DJ, 5.6 × 1013 gc/mL;
AAV-CMV-FLExloxP-eGFP-2A-TeTxLc, serotype DJ, 2.1 × 1012 gc/mL;
AAV-hSyn-FLExloxP-ChR2(H134R)-YFP, serotype DJ, 1.4 × 1013 gc/mL;
AAV-hSyn-FLExloxP-YFP, serotype DJ, 1.5 × 1013 gc/mL;
AAV-EF1α-FLExloxP-GCaMP6f, serotype 5, 1.9 × 1013 gc/mL;
AAV-hSyn-FLExFRT-mGFP-2A-synaptophysin-mRuby, serotype DJ, 3.7 × 1012 
gc/mL;
AAV-hSyn-FLExFRT-hM4Di-mCherry, serotype DJ, 2.9 × 1013 gc/mL;
AAV-hSyn-FLExFRT-hM3Dq-mCherry, serotype DJ, 4.6 × 1013 gc/mL;
AAV-hSyn-FLExFRT-Kir2.1-T2A-GFP, serotype DJ, 7.2 × 1013 gc/mL;
AAV-hSyn-FLExFRT-ChR2(H134R)-YFP, serotype DJ, 5.2 × 1012 gc/mL;
AAV-hSyn-FLExFRT-YFP, serotype DJ, 4.3 × 1012 gc/mL;
AAV-EF1α-FLExFRT-bReachES-mCherry, serotype 5, 2.5 × 1013 gc/mL;
AAV-hSyn-FLExOFFloxP-hM4Di-mCherry, serotype DJ, 1.1 × 1013 gc/mL;
AAV-hSyn-FLExOFFloxP-hM3Dq-mCherry, serotype DJ, 1.2 × 1013 gc/mL;
AAV-hSyn-FLExOFFloxP-Kir2.1-T2A-GFP, serotype DJ, 7.8 × 1012 gc/mL;
AAV-hSyn-FLExOFFloxP-YFP, serotype DJ, 1.4 × 1013 gc/mL;
CAV-FLExloxP-Flp, 5.0 × 1012 gc/mL;
RVdG, 5.0 × 108 colony forming units (cfu)/mL (both GFP and mCherry)
Rabies input tracing + targeted input activity manipulations
For tracing inputs from VTA-DA neurons while manipulating input regions, we used either 
DAT-Cre;PV-Flp double heterozygotes (for GPe manipulations) or DAT-Cre;A2a-Cre double 
heterozygotes (for NAcMedS manipulations) between 4-6 weeks of age.
To manipulate GPe-PV neurons, in DAT-Cre;PV-Flp mice, 100 nL of a 1:1 volume mixture 
of AAV-CAG-FLExloxP-TC and AAV-CAG-FLExloxP-G was injected into the VTA of both 
hemispheres, and 300 nL of AAV-FLExFRT-hM4Di, AAV-FLExFRT-hM3Dq, AAV-
FLExFRT-Kir2.1, or AAV-FLExFRT-YFP was injected into the GPe. Both hemispheres were 
used for each animal, and counted independently. AAV-FLExFRT-hM4Di and AAV-
FLExFRT-hM3Dq were injected into the same animals, as were AAV-FLExFRT-Kir2.1 and 
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AAV-FLExFRT-YFP. One month later, RVdG was injected bilaterally into the VTA. To 
activate DREADDs, animals were injected once every 12 hours with CNO for five days 
beginning immediately after RVdG injection.
To manipulate NAcMedS-D1 neurons, in DAT-Cre;A2a-Cre mice, 100 nL of a 1:1 volume 
mixture of AAV-FLExloxP-TC and AAV-FLExloxP-G was injected into the VTA of both 
hemispheres, and 300 nL of either AAV- FLExOFFloxP-hM4Di, AAV- FLExOFFloxP-
hM3Dq, AAV- FLExOFFloxP-Kir2.1, or AAV-FLExOFFloxP-YFP was injected into the 
NAcMedS. Both hemispheres were used for each animal, and counted independently. AAV-
FLExOFFloxP-hM4Di and AAV-FLExOFFloxP-hM3Dq were injected into the same animals, 
as were AAV-FLExOFFloxP-Kir2.1 and AAV-FLExOFFloxP-YFP. One month later, RVdG 
was injected bilaterally into the VTA.
For both GPe and NAcMedS manipulations, in animals injected with hM4Di-mCherry or 
hM3Dq-mCherry, an RVdG that expressed GFP was used; if the AAV expressed GFP or 
YFP, RVdG expressing mCherry was used.
Due to the large sample sizes of the experiments involving targeted input activity 
manipulations, only inputs from the GPe and NAc were quantified. Inputs from the 
NAcCore and NAcLatS were used for normalization because the percentage of total rabies-
labeled inputs from these regions was relatively invariant, regardless if injections were 
located more medially or laterally in the VTA7, or if a drug of abuse had been injected (Fig. 
1, Extended Data Fig. 1a).
Rabies input tracing with two-day LMS procedure
To examine the relationship between rabies-labeled inputs in the GPe and the locomotor 
sensitization to cocaine injections using a two-dose procedure, in DAT-Cre mice, 100 nL of a 
1:1 volume mixture of AAV-FLExloxP-TC and AAV-FLExloxP-G was injected into the VTA. 
On days 1-2, mice received IP injections of saline and were habituated to an open field 
chamber equipped with infrared lasers for motion tracking. On day 3, animals were injected 
with one of the following: cocaine (15 mg/kg), amphetamine (1 mg/kg), nicotine (0.5 mg/
kg), or morphine (10 mg/kg) and placed in the same open field chamber. On day 4, RVdG 
was injected into the VTA. On day 9, animals were injected with the same dose of the same 
drug they had received on day 3, and their locomotion was tracked in the open field. 
Animals were sacrificed immediately thereafter. The rabies-labeled inputs in the GPe were 
quantified, and normalized to the sum of inputs from the NAcLat and NAcCore.
Axon projection quantification
Images were obtained and quantified as previously described7, except that three sections 
were used for each region and were averaged to obtain the final value. Four brains were used 
for each experiment.
Synaptic puncta quantification
Methods for synaptic puncta quantification were adapted from Mosca and Luo42 for use in 
mice. To quantify the volume and density of mRuby-labeled puncta from GPe-PV neuron 
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termini in the SNr, 300 nL of AAV-FLExloxP-mGFP-2A-synaptophysin-mRuby was injected 
into the GPe of PV-Cre mice, and sections were cut at a thickness of 60 μm. Floating 
sections were stained using anti-mCherry and anti-GFP antibodies. Sections were imaged on 
a Zeiss 510 confocal microscope using a 63× objective, with image stacks containing 30 
sections at 0.44 μm intervals using 2× averaging and 2× optical zoom. Three images were 
taken of puncta in the SNr as well as in the STN for each brain. Images were analyzed using 
Imaris (Bitplane). The surface function was used to obtain the volume of mGFP+ neurites 
and mRuby-positive puncta, while the spots function was used to estimate the number of 
mRuby puncta. Data from the three slices from the SNr and STN were averaged for each 
brain. Measurements from the SNr were normalized to those from the STN.
Quantification of Fos immunostaining
To quantify integrated neural activity, Cre-dependent AAVs expressing YFP, hM4Di, ChR2, 
or Kir2.1 were injected into the GPe of PV-Cre mice and relative activation of VTA-DA 
neurons was measured by the ratio of Fos+ neurons in the ventral midbrain that co-stained 
with tyrosine hydroxylase (TH) to all Fos+ neurons in the ventral midbrain (Fig. 5g-i). 
Animals were sacrificed 90 minutes after the final stimulus (optical stimulation at 20 Hz for 
thirty minutes in ChR2-expressing animals, or cocaine/saline injection). When cocaine or 
saline was injected in animals expressing hM4Di, CNO was injected thirty minutes prior to 
cocaine or saline injection. Animals were transcardially perfused, and brains sectioned on a 
vibratome in PBS. Sections were blocked with 10% normal donkey serum (NDS) and 2% 
BSA/0.5% triton-X100 in PBS (PBST), then stained with TH and Fos antibodies, in 1% 
NDS in PBST at 4 degrees for four nights. Sections were rinsed three times for 30 minutes 
each at room temperature, followed by secondary antibody stain in 1% NDS in PBST at 4 
degrees for two nights. Sections were then rinsed three times for 30 minutes each, and 
mounted on slides. The midbrain from three representative VTA-containing sections were 
then imaged on a Zeiss LSM 780 confocal microscope at 20× magnification, and the results 
averaged together for each brain. For activation of GPe neurons for Fos immunostaining, 
300 nL of AAV-FLExloxP-ChR2 was injected bilaterally into the GPe of PV-Cre mice, and 
200 μm, 0.39NA optical fibers were implanted over the VTA. For stimulation, the optical 
fiber was connected to a 473 nm laser diode (OEM Laser systems) through an FC/PC 
adaptor. Laser output was controlled using a Master-8 pulse stimulation, which delivered 5 
ms light pulses at 20 Hz. Light output through the optical fibers was adjusted to 20 mW 
using a digital power meter console. Images were taken with a constant exposure time. Cells 
with a visually identifiable nuclear label by eye were considered Fos+.
Immunohistochemistry
The following primary antibodies were used: Rat anti-mCherry, Life Sciences, 1:2000; 
chicken anti-GFP, Aves Labs, 1:1000; rabbit anti-TH, Millipore, 1:1000; Goat anti-Fos, 
Santa Cruz, 1:500. The following secondary antibodies were used from Jackson 
ImmunoResearch at a concentration of 1:250: donkey anti-chicken AlexaFluor488; donkey 
anti-goat AlexaFluor488; donkey anti-rat AlexaFluor555; donkey anti-goat AlexaFluor555; 
donkey anti-rabbit AlexaFluor647.
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Fiber photometry
To assess cocaine-induced changes in neuronal activity in vivo, fiber photometry was used43. 
750nL of AAV-FLExloxP-GCaMP6f was injected into the GPe of PV-Cre mice, and a 400 
μm diameter, 0.48NA optical fiber (Doric Lenses) was implanted at the same location. To 
test the effect of GPe-PV neuron stimulation on VTA-DA neuron activity, 300 nL of AAV-
FLExFRT-bReachES was injected into the GPe, and 750 nL of AAV-FLExloxP-GCaMP6f 
was injected into the VTA of DAT-Cre;PV-Flp mice. A 400 μm diameter, 0.48NA optical 
fiber was implanted over the VTA, and a 200 μm, 0.39NA fiber (made in-house) was 
implanted over the GPe. Implants were secured to the skull with metal screws (Antrin 
Miniature Specialists), Metabond (Parkell), and Geristore dental epoxy (DenMat). Mice 
were allowed to recover for at least 4 weeks prior to experiments.
Fiber photometry recordings were made using previously described equipment9. Briefly, 405 
nm and 470 nm excitation light was used to excite GCaMP6f at its isosbestic and calcium-
dependent wavelengths to obtain both a control and calcium signal in the same animal, 
respectively. To activate bReachES-expressing GPe-PV neurons, a 594 nm laser was 
controlled by a Master-8 pulse stimulation (A.M.P.I) that delivered 5 ms pulses at 40 Hz. 
Light output through the optical fibers was adjusted to 10 mW using a digital power meter 
console (Thorlabs). Light was manually switched on at 10 minutes and off at 20 minutes.
All data analysis was performed in MATLAB. Signals were first motion corrected by 
subtracting the least squares best fit of the control trace to the calcium signal. Data points 
containing large motion artifacts were then manually removed. To assess neural activity, the 
median absolute deviation (MAD) was calculated across the entire photometry trace during a 
given session. We conservatively defined a threshold of 6*MAD to assess bouts of high 
neural activity. During each session, we calculated the percentage of time that the 
photometry trace was greater than or equal to 6*MAD of the entire trace. For Fig. 2i-k n = 
11, and Fig. 5k-m n = 9.
Whole-cell recordings
Mice were deeply anaesthetized with isoflurane, and coronal midbrain or GPe slices (250 
μm) were prepared after intracardial perfusion with ice-cold artificial cerebrospinal fluid 
(ACSF) containing (in mM): 230 sucrose, 10 glucose, 25 NaHCO3, 2.5 KCl, 1.2 NaH2PO4, 
0.5 CaCl2, 7 MgCl2, and oxygenated with 95% O2/5% CO2. After 60 min of recovery, 
slices were transferred to a recording chamber and perfused continuously at 2–4 ml/min with 
oxygenated ACSF containing (in mM): 120 NaCl, 10 glucose, 25 NaHCO3, 2.5 KCl, 1.2 
NaH2PO4, 2.5 CaCl2, 2.3 MgCl2 at 30 °C. Patch pipettes (3.8-4.4 MΩ) were pulled from 
borosilicate glass (G150TF-4; Warner Instruments) and filled with internal solution 
containing (in mM): 131 CsCH3SO3, 10 HEPES, 10 glucose, 2 CaCl2, 10 EGTA, 5 MgATP, 
0.4 NaGTP, 10 phosphocreatine, 5 QX314, and 0.2% biocytin (pH 7.3, 292 mOsm) for 
voltage clamp recordings. For analysis of GPe excitability, the internal solution contained (in 
mM): 130 KMeSO3, 9 KCl, 0.1 EGTA, 10 HEPES, 4 Mg-ATP, 0.4 Na-GTP, 7.5 
Na2phosphocreatine, adjusted to pH 7.3 with KOH, 290-295 mOsm. Input resistance and 
access resistance were monitored continuously throughout each experiment; experiments 
were terminated if these changed by >20%.
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Labeled neurons were visualized with a 40× water-immersion objective on an upright 
fluorescent microscope (BX51WI; Olympus) equipped with infrared-differential 
interference contrast video microscopy and epifluorescence (Olympus). ChR2 was 
stimulated by flashing 473-nm light (2 ms pulses, 0.1 Hz, 10 mW) through the light path of 
the microscope using an ultrahigh-powered light-emitting diode (LED) powered by an LED 
driver (Thorlabs) under computer control. The light intensity of the LED was not changed 
during the experiments. A dual lamp house adaptor (Olympus) was used to switch between 
the fluorescence lamp and LED light source.
For monosynaptic connectivity analysis, D-APV (50 μM) and NBQX (10 μM) were added to 
block NMDA receptors and AMPA receptors, respectively, and tetrodotoxin (TTX, 1 μM), a 
voltage-gated sodium channel antagonist, and 4-aminopyridine (4-AP, 1mM), a potassium 
channel antagonist, were added to isolate monosynaptic connections44. The IPSC amplitude 
plotted in Fig. 5c only included cells with detectable optically-evoked IPSCs.
For analysis of quantal size and frequency from GPe inputs to SNr neurons, we replaced 
calcium in the ACSF with 4 mM SrCl2 to induce asynchronous vesicle release. The 
amplitude and frequency of events occurring between 50 ms and 250 ms after the blue light 
pulse were recorded. The amplitude of each event was measured from a local baseline 
established 5-10 ms before the light pulse. All electrophysiology data were collected using 
Axograph software.
Behavioral assays of locomotor sensitization (LMS) and conditioned place preference 
(CPP)
To test the necessity of GPe-PV neuron activity for the development of LMS or CPP, 300 nL 
of AAV-FLExloxP-hM4Di, AAV-FLExloxP-Kir2.1, AAV- FLExloxP-TeTxLc, or AAV-
FLExloxP-YFP was injected bilaterally into the GPe of PV-Cre animals.
To assay for drug-induced CPP, animals were first tested in a single drug pairing, two-
chamber CPP test. Each chamber was given either a clear, textured or black, smooth floor. 
On the first day, animals were initially placed into the right chamber, and allowed to freely 
explore both chambers for thirty minutes (pre-test). The second day, animals were saline-
conditioned to the left side, and the following day, cocaine (or morphine)-conditioned to the 
right side. Drug conditioning on the black, smooth or clear, textured floor was counter-
balanced across the mice. On the fourth day, animals were again initially placed into the 
right chamber, and allowed to explore freely (post-test). For animals injected with CNO, 10 
mg/kg CNO was injected thirty minutes before the beginning of the cocaine and saline 
pairings.
The following week, to test LMS, animals were habituated to open field boxes equipped 
with motion tracking for two days (receiving saline injections before each session). Animals 
were then injected with cocaine (or morphine) immediately before entry into the open-field 
boxes, for five consecutive days, for 30 minutes each. For animals injected with CNO, CNO 
was injected thirty minutes before the beginning of each session. In Extended Data Fig. 5, 
both YFP and hM4Di-expressing animals were given CNO 30 minutes prior to morphine 
injection.
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To inhibit GPe-PV→midbrain neurons, 500 nL of CAV2-FLExloxP-Flp was injected into the 
SNr, and 300 nL of AAV-FLExFRT-Kir2.1 was injected into the GPe of PV-Cre mice. All 
injections were bilateral. Animals were tested 2 weeks later.
To inhibit GPe-PV terminals in the midbrain, animals were injected with 300 nL of AAV-
FLExloxP-YFP or AAV-FLExloxP-hM4Di in the GPe, and a bilateral cannula guide (C235G, 
26GA, C/C distance 1.8 mm, 5 mm pedestal, cut 3.5 mm below pedestal, custom specified 
for mouse bilateral VTA coordinates, Plastics One) was implanted over the VTA 
(coordinates AP −3.5, ML 0.9, DV −3.13). 2 skull screws were implanted for headcap 
stability, and headcaps were sealed with Metabond and Geristore. CNO microspheres were 
synthesized to enable slow release of CNO after a single infusion. Degradex PLGA CNO 
microspheres were custom ordered from Phosphorex (Hopkinton, MA). Beads of target 
mean diameter = 1 μm were dissolved in 0.5% trehalose at a concentration of 5 mg 
microsphere/mL. The estimated CNO loading efficiency was 5%, the estimated burst release 
was 50%, and the estimated release time was 7 days. The target concentration of CNO 
release at a steady state was 100pg/hr23, 45.
On day 1 of the behavioral protocols, animals were given an IP saline injection. On day 2, 
one hour prior to locomotor testing, all cannula guides were pierced with a dummy infuser 
(C235I, 33GA, project 1.5 MM past guide), and mice were given an IP saline injection one 
hour later. On day 3, CNO microspheres were infused one hour prior to locomotor testing, 
250 nL per side at 250 nL/min, and mice were given an IP saline injection one hour later and 
tested for effects on basal locomotion. On days 3-6 (starting the same afternoon), animals 
were run through the CPP protocol and the LMS protocol on days 6-10. We then waited a 
week for CNO washout, and repeated the standard CPP and LMS procedures without 
subsequent infusions in hM4Di-expressing animals.
For manipulations of SNr-GABA neurons, 500 nL of AAV-FLExloxP-hM3Dq was injected 
bilaterally into the SNr of GAD2-Cre mice, or 500 nL of AAV-FLExloxP-hM4Di was 
injected into the SNr and 300 nL of AAV-FLExFRT-Kir2.1 was injected into the GPe of 
GAD2-Cre;PV-Flp animals. All injections were bilateral.
Data analyses and statistics
All statistics were calculated using GraphPad Prism 7 software. Statistical significance was 
assessed by paired t-tests with the exception of Fig. 2n, where a two-way ANOVA was used, 
and Fig. 2k and 5m where a one-way ANOVA was used with the Geisser-Greenhouse 
correction followed by post-hoc Wilcoxon matched-pairs signed rank tests. Dot plots 
presented throughout the manuscript include a horizontal line representing the mean value 
for each group. In Fig. 1 and Extended Data Fig. 1, the length of each bar represents the 
mean. Error bars represent SEM throughout. For all figures, ns p > 0.05, * p ≤ 0.05, ** p ≤ 
0.01, *** p ≤ 0.001, **** p ≤ 0.0001.
Data availability
Numerical data for each figure is included with the manuscript as source data. All other data 
will be available from the authors upon reasonable request.
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Extended Data
Extended Data Figure 1. Changes to VTA-DA inputs induced by drugs of abuse
a, Quantification of monosynaptic inputs to VTA-DA neurons labeled in animals receiving 
single dose administration of either cocaine, amphetamine, nicotine, morphine, saline, or 
fluoxetine one day prior to injection of RVdG into the VTA. Data were combined to generate 
Fig. 1c. b, Sample images of GPe neurons labeled by RVdG and co-stained for PV. Pie 
graph shows proportion of labeled cells that co-stained for PV. c, Sample images of 
NAcMedS neurons labeled by RVdG in DAT-Cre;D1-tdTomato mice. Pie graph shows 
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proportion of labeled cells that were D1+ as defined by presence of tdTomato (scale bars = 
50 μm).
Extended Data Figure 2. Axonal projections of GPe-PV neurons
a, AAV-FLExloxP-mGFP was injected into the GPe of PV-Cre animals, and mGFP+ axons 
were quantified throughout the brain. b, Quantification of fraction of mGFP+ axons in the 
indicated brain regions. c, Sample image of mGFP+ axons in the ventral midbrain (scale bar 
= 500 μm). d, Quantification of fraction of mGFP+ axons in the indicated ventral midbrain 
brain regions. The schematics of the mouse brain in this figure were adapted from ref. 33.
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Extended Data Figure 3. Inhibition of GPe-PV neuron activity modestly affects cocaine-induced 
locomotion
a, Cre-dependent AAVs expressing YFP, hM4Di, Kir2.1, or TeTxLc were injected into the 
GPe of PV-Cre animals. b, Quantification of effects of CNO on basal locomotion in animals 
expressing YFP or hM4Di (compared to YFP + saline: YFP + CNO, p = 0.36; hM4Di + 
CNO, p = 0.59). c, Quantification of basal locomotion during GPe-PV neuron inhibition 
(hM4Di, p = 0.54; Kir2.1, p = 0.66; TeTxLc, p = 0.27). d, Quantification of cocaine-induced 
locomotion during GPe-PV neuron inhibition (hM4Di, p = 0.37; Kir2.1, p = 0.12; TeTxLc, p 
= 0.002). The schematics of the mouse brain in this figure were adapted from ref. 33.
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Extended Data Figure 4. Labeled GPe inputs to the VTA correlated with LMS
a, AAV-FLExloxP-TC and AAV-FLExloxP-G were injected into the VTA of DAT-Cre mice. 
Eleven days later, animals were habituated for two days to an open field chamber, and given 
a drug injection the following day. RVdG was injected one day after the drug. Five days after 
RVdG injection, the animal was given a second injection of the same drug in the open field. 
b, Normalized labeled GPe inputs plotted against the relative locomotion in session 2 vs. 
session 1 for cocaine (n = 34), amphetamine (n = 5), nicotine (n = 5), and morphine (n = 5). 
Regression line is plotted for all drugs combined. c-e, Labeled GPe inputs after a single dose 
of cocaine significantly correlated with LMS (c), but not total locomotion after the first (d) 
or second (e) dose of cocaine. f-h, Plots of labeled GPe inputs vs. LMS for (f) amphetamine 
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(1 mg/kg), (g) nicotine (0.5 mg/kg), or (h) morphine (10 mg/kg). The schematics of the 
mouse brain in this figure were adapted from ref. 33.
Extended Data Figure 5. Inhibition of the GPe prevents morphine LMS and CPP
a, A Cre-dependent AAV expressing either YFP or hM4Di was injected into the GPe of PV-
Cre animals. b, c, Quantification of LMS (b; p = 0.022) and CPP (c; p = 0.0005) in animals 
in which YFP or hM4Di (activated by CNO) were expressed in GPe-PV neurons. The 
schematics of the mouse brain in this figure were adapted from ref. 33.
Extended Data Figure 6. Inhibition of GPe-PV→midbrain projection neurons blocks cocaine 
CPP and LMS
a, CAV-FLExloxP-Flp was injected into the ventral midbrain, and AAV-FLExFRT-Kir2.1 or 
AAV-FLExFRT-YFP was injected into the GPe of PV-Cre mice. b, c, Quantification of LMS 
(b; p = 0.019) and CPP (c; p = 0.0067) in animals in which YFP or Kir2.1 were expressed in 
GPe-PV neurons projecting to the ventral midbrain. The schematics of the mouse brain in 
this figure were adapted from ref. 33.
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Extended Data Figure 7. GPe-PV→midbrain neurons collateralize to multiple subcortical 
targets
a, CAV-FLExloxP-Flp was injected into the ventral midbrain, and AAV-FLExFRT-mGFP was 
injected into in the GPe of PV-Cre mice. b, Representative image of mGFP+ collaterals in 
the thalamus and subthalamic nucleus (STN) (scale bar = 500 μm). c, Quantification of 
projection fraction of collaterals to indicated target regions. The schematics of the mouse 
brain in this figure were adapted from ref. 33.
Extended Data Figure 8. DA neuron activity is required for the development of LMS and CPP
a, Breeding scheme for experiments. LSL = loxP stop loxP. b, c, Quantification of LMS (b; 
p = 0.001) and CPP (c; p = 0.005) in control animals or animals expressing hM4Di in DA 
neurons receiving CNO.
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Extended Data Figure 9. Map of anatomical location of ventral midbrain cells from which whole 
cell recordings were made
Individual dots indicate location of cells in which ChR2-evoked IPSCs due to ChR2 
expression in GPe-PV neurons could be detected (connected) or not (not connected) in 
NAcLat-projecting (a) or NAcMed-projecting (b) VTA-DA neurons, and SNr-GABA (c) or 
VTA-GABA (d) cells. The schematics of the mouse brain in this figure were adapted from 
ref. 33.
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Extended Data Figure 10. GPe-PV neurons mediate their effects through SNr-GABA neurons
a, Procedure to test LMS and CPP during SNr-GABA activation. b, c, Activating SNr-
GABA neurons with CNO prevented LMS (b; p = 0.010) and CPP (c; p = 0.015). d, 
Injection strategy to test if SNr-GABA neurons are downstream of GPe-PV neurons. e, f, 
While expression of Kir2.1 in GPe-PV neurons prevented LMS and CPP, this suppression 
was overcome by concurrent inhibition of SNr-GABA neurons (e; p = 0.035, f; p = 0.036). 
The schematics of the mouse brain in this figure were adapted from ref. 33.
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Figure 1. Cocaine-induced changes to VTA neuron inputs
a, Strategy for labeling inputs to VTA-DA neurons. b, Fraction of total GFP+ inputs from 
each site relative to total quantified inputs. Highlighted regions represent p < 0.05 (p = 0.04, 
0.04, 0.02, 0.02 for EAM, EP, GPe, and ZI, respectively). c, Combined data for 
administration of drug of abuse (n = 4, 5, 5, 4 for cocaine, amphetamine, morphine, and 
nicotine, respectively) or control (saline, n = 4; fluoxetine, n = 3: p = 0.005, 0.007, 0.05, 
0.05 for GPe, MHb, NAcMedS, and Ant. Ctx., respectively). d, e, Strategy (d) and 
quantification (e) of labeling inputs to ventral midbrain GABA neurons (GPe, p = 0.01). In 
this and subsequent figures, unless otherwise noted, all statistical analyses used paired t-
tests, and error bars represent SEM. See Methods for abbreviations of anatomical terms. The 
schematics of the mouse brain in this figure were adapted from ref. 33.
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Figure 2. Cocaine triggers increase in GPe-PV neuron activity and excitability
a, AAV-FLExloxP-mGFP-2A-synaptophysin-mRuby was injected in GPe of PV-Cre mice to 
quantify mRuby+ puncta in SNr. b, mGFP+ neurites and mRuby+ puncta from GPe-PV 
neurons in SNr (scale = 10 μm). c, d, No change in density (c; p = 0.99) or volume (d; p = 
0.76) of mRuby puncta was observed. e, AAV-FLExFRT-ChR2 was injected into GPe of PV-
Flp mice, and recordings conducted from SNr-GABA neurons in slices from cocaine or 
saline-treated animals. f, Trace from SNr neuron highlighting the time window for analysis. 
g, h, No change in quantal IPSC amplitude (g; p = 0.94) or frequency (h; p = 0.94) was 
observed. i, AAV-FLExloxP-GCaMP6f was injected into GPe of PV-Cre animals to measure 
PV neuron activity using fiber photometry. j, Traces showing ΔF/F following the first saline, 
cocaine, and second saline injections. Red = activity threshold of six times the median 
absolute deviation. k, Percent time activity surpassed threshold (one-way ANOVA, p = 
0.018; post-hoc tests day 1 vs. 2, p = 0.17; day 1 vs. 3, p = 0.0049). l, AAV-FLExloxP-GFP 
was injected into GPe of PV-Cre mice, and recordings made from GFP+ cells. m, Traces 
from depolarizing current injections. n, Frequency of action potentials over range of current 
steps (p < 0.0001 for saline vs. cocaine, two-way ANOVA). For this and all subsequent 
figures, ns p > 0.05, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Dot plots 
include horizontal line representing mean. The schematics of the mouse brain in this figure 
were adapted from ref. 33.
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Figure 3. Bidirectional modulation of rabies labeling by activity manipulations
a, A mixture of AAV-FLExloxP-TC and AAV-FLExloxP-G was injected into VTA while an 
AAV expressing a Flp-dependent YFP, hM4Di, Kir2.1, or hM3Dq was injected into GPe. b, 
Image of rabies labeling in GPe (scale = 1 mm). c, Experimental strategy for d-e. d, 
Quantification of labeled inputs in GPe when GPe was manipulated. y-axis = labeled GPe 
inputs/(NAcLat + NAcCore inputs). Combined controls (uninjected and YFP) were assigned 
a value of 1. GPe inhibition reduced (hM4Di, p = 0.004; Kir2.1, p < 0.0001) while activation 
increased (hM3Dq, p = 0.016) labeled inputs. e, Quantification of labeled inputs in 
NAcMedS following GPe activity manipulations (hM4Di, p = 0.98; Kir2.1, p = 0.90; 
hM3Dq, p = 0.88). f, Experimental strategy for g-h. g, NAcMedS-D1 inhibition had no 
effect on labeling of GPe inputs (hM4Di, p = 0.13; Kir2.1, p = 0.65) while activation 
increased labeling (hM3Dq, p < 0.001). h, NAcMedS-D1 inhibition decreased (hM4Di, p = 
0.02; Kir2.1, p = 0.03) while activation increased (hM3Dq, p = 0.007) labeling of NAcMedS 
inputs. The schematics of the mouse brain in this figure were adapted from ref. 33.
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Figure 4. GPe-PV neuron activity is required for cocaine-induced LMS and CPP
a, Cre-dependent AAVs were injected into GPe of PV-Cre animals. b, Plot of locomotor 
activity for a single animal. c, GPe-PV inhibition blocked cocaine-induced LMS (hM4Di, p 
= 0.0002; Kir2.1, p = 0.007; TeTxLc, p = 0.008). d, Procedure to test CPP during GPe-PV 
inhibition. e, Trace from YFP animal during post-test. f, GPe-PV inhibition prevented CPP 
(hM4Di, p = 0.019; Kir2.1, p = 0.030; TeTxLc, p = 0.029). g, Slow-release CNO 
microspheres were injected into ventral midbrain in animals expressing hM4Di or YFP in 
GPe-PV neurons. h, i, Both LMS (h; p = 0.0005) and CPP (i; p = 0.0094) were blocked in 
hM4Di-expressing animals. When tested again after CNO washout, these same animals 
developed LMS (h; p = 0.047) and CPP (i; p = 0.0078). The schematics of the mouse brain 
in this figure were adapted from ref. 33.
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Figure 5. GPe-PV neurons disinhibit VTA-DA neurons
a, AAV-FLExFRT-ChR2 was injected into GPe, AAV-FLExloxP-GFP injected in VTA, and 
retrobeads injected into NAcLatS or NAcMedS of DAT-Cre;PV-Flp or GAD2-Cre;PV-Flp 
mice. Whole-cell recordings were made from identified midbrain neurons in acute slices. b, 
Example light-evoked IPSCs. c, Quantification of percent connectivity and IPSC amplitude 
for each cell type. d, AAV-FLExloxP-TC66T and AAV-FLExloxP-G were injected into VTA 
of DAT-Cre mice, followed two weeks later by RVdG. e, Sample labeling of midbrain 
section (scale = 1 mm). f, Quantification of labeled local inhibitory inputs. g, Cre-dependent 
AAVs expressing YFP, hM4Di, Kir2.1, or ChR2 were injected into GPe of PV-Cre mice 
followed by quantification of Fos labeling. h, i, Sections of ventral midbrain showing Fos 
labeling (green) and tyrosine hydroxylase (TH) labeling (magenta) in animals receiving 
cocaine injections and expressing YFP (h) or hM4Di (i) in GPe. Arrows indicate Fos+ 
neurons co-expressing TH (scale = 200 μm). j, Quantification of activated DA neurons (Fos+ 
TH+) relative to all activated ventral midbrain neurons (Fos+) (cocaine-YFP, p = 0.029; 
ChR2, p < 0.0001). k, Flp-dependent bReachES was injected in GPe and a Cre-dependent 
GCaMP6f was injected in VTA of DAT-Cre;PV-Flp mice. l, Fiber photometry traces during 
consecutive 10 min epochs. m, VTA-DA neurons were more active during light-on than 
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light-off (one-way ANOVA, p = 0.014; post-hoc tests 0-10 vs. 10-20 min, p = 0.008; 10-20 
vs. 20-30 min, p = 0.039). n, Proposed circuit diagram before and after cocaine. Size of cell 
body and arrows represent activity strength. The schematics of the mouse brain in this figure 
were adapted from ref. 33.
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